Venture CapitalRIA · CRD 322625Exempt Reporting AdviserPrivate Fund Adviser

Updated:

Suncoast Ventures

Suncoast Ventures is a venture capital based in Walnut Creek, founded 2021; the Altss profile covers its classification, headquarters, registration, AUM band,...

Suncoast Ventures logo

Suncoast Ventures

Suncoast Ventures is an exempt reporting adviser with its headquarters in Walnut Creek, CA. It provides investment advice to clients.

General information

Firm type

Venture Capital

Year founded

2021

Location

Region

North America

Country

United States

City

Walnut Creek

Corporate office

San Diego, CA, United States

Principals

Genevieve LeMarchal

Managing Partner

Hal Walbrink

Venture Partner

Ray Costantini

Venture Partner

Tammy Mahaney

Venture Partner

Russ Nash

Venture Partner

Charla Triplett

Advisor

Joe Geraci

Scientific Advisor — AI, ML, Quantum

Sector focus

Digital HealthMedTechMedical AIWomen's HealthPediatricsConsumer HealthHealth EquityGlobal Health

Frequently asked questions

Who runs investment decisions at Suncoast Ventures?

Managing Partner Genevieve LeMarchal leads investment decisions. She built the firm's investment model after running Expert Dojo's healthcare accelerator and serving as a GP at FoundersPad VC Fund II. The venture partner bench includes former operators like Dr. Ray Costantini (Bright.MD) and Hal Walbrink (Xinetix), but the firm's website does not detail a formal investment committee structure.

What investment stages does Suncoast typically target?

Suncoast targets early-stage healthcare companies from seed to growth. The firm's own description mentions early stage, seed, and startup phases, while its portfolio includes companies ranging from pre-revenue therapeutics to growth-stage digital health platforms. Specific round participation is not disclosed per company, but co-investors like Techstars and Cedars-Sinai Accelerator indicate seed-stage activity.

Which sectors does Suncoast explicitly avoid?

Suncoast has not published explicit exclusion criteria. Its portfolio is entirely healthcare-focused, with no disclosed investments outside digital health, medtech, medical AI, consumer health, and life sciences. The firm's stated thesis — "$1B healthcare problems hiding in plain sight" — and its clinical operator team composition strongly indicate a singular healthcare mandate, effectively excluding sectors like fintech, enterprise software, or climate.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Walnut Creek Venture Capital profiles